TELA Bio annual return on equity
2020
2021
2022
2023
2024
2025
TELA Bio Return on Equity (ROE) Growth & History (TELA)
TELA Bio's return on equity was −223.35% for fiscal 2025.
View full TELA Bio company overviewTELA Bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −223.35% | −63.48 pp |
| 2024 | 2024-12-31 | −159.87% | +121.35 pp |
| 2023 | 2023-12-31 | −281.23% | −23.71 pp |
| 2022 | 2022-12-31 | −257.51% | −161.23 pp |
| 2021 | 2021-12-31 | −96.28% | −24.28 pp |
| 2020 | 2020-12-31 | −72.00% | — |
TELA Bio quarterly return on equity
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −2,207.37% | −2159.01 pp |
| Q4 2025 | 2025-12-31 | −229.76% | −146.75 pp |
| Q3 2025 | 2025-09-30 | −160.19% | — |
| Q2 2025 | 2025-06-30 | −72.68% | +73.38 pp |
| Q1 2025 | 2025-03-31 | −48.36% | −14.33 pp |
| Q4 2024 | 2024-12-31 | −83.01% | −30.86 pp |
| Q2 2024 | 2024-06-30 | −146.05% | −96.04 pp |
| Q1 2024 | 2024-03-31 | −34.04% | +103.84 pp |
| Q4 2023 | 2023-12-31 | −52.15% | +0.92 pp |
| Q3 2023 | 2023-09-30 | −31.06% | +67.42 pp |
| Q2 2023 | 2023-06-30 | −50.02% | +249.91 pp |
| Q1 2023 | 2023-03-31 | −137.88% | −65.79 pp |
| Q4 2022 | 2022-12-31 | −53.07% | −17.03 pp |
| Q3 2022 | 2022-09-30 | −98.48% | −72.11 pp |
| Q2 2022 | 2022-06-30 | −299.93% | −278.39 pp |
| Q1 2022 | 2022-03-31 | −72.09% | −54.15 pp |
| Q4 2021 | 2021-12-31 | −36.04% | −21.25 pp |
| Q3 2021 | 2021-09-30 | −26.37% | −13.50 pp |
| Q2 2021 | 2021-06-30 | −21.54% | −7.66 pp |
| Q1 2021 | 2021-03-31 | −17.94% | +8.23 pp |
| Q4 2020 | 2020-12-31 | −14.79% | — |
| Q3 2020 | 2020-09-30 | −12.87% | — |
| Q2 2020 | 2020-06-30 | −13.88% | — |
| Q1 2020 | 2020-03-31 | −26.16% | — |
TELA Bio return on equity trends
Over the last five fiscal years, TELA Bio's return on equity decreased from −72.00% to −223.35%, a change of −151.36 percentage points. The latest reported quarter, Q1 2026, shows −2,207.37%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TELA Bio source filings ↗